help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nippoldt, T. B.
Right arrow Articles by Marshall, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nippoldt, T. B.
Right arrow Articles by Marshall, J. C.

Journal of Clinical Endocrinology & Metabolism, Vol 69, 67-76, Copyright © 1989 by Endocrine Society


ARTICLES

The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle

TB Nippoldt, NE Reame, RP Kelch and JC Marshall
Department of Internal Medicine, University of Michigan, Ann Arbor 48109.

During the luteal phase of the menstrual cycle, plasma progesterone (P) and estradiol (E2) concentrations are elevated, and LH (and by inference GnRH) pulse frequency is slow. In contrast, LH pulse frequency increases during the early follicular phase when plasma E2 and P are lower. To examine the mechanism(s) responsible for the slower GnRH pulse frequency in the luteal phase, we maintained plasma P, E2, or both at midluteal concentrations from the midluteal phase to the time of the next early follicular phase and measured the effects on LH secretion. Thirteen normal women with regular menstrual cycles were studied during two or three cycles. Blood was obtained every 10 min during 10-h studies. Control cycle luteal and early follicular studies were followed by a second control study in the luteal phase of the treatment cycle. P (six women), E2 (seven women), or both (five women) then were given twice daily by im injection for 6-12 days until the day corresponding to the early follicular study of the control cycle (EF + P, EF + E2, or EF + E2 + P). A final study was performed 1 week after the injections were discontinued (F). LH pulse frequency was low in the midluteal phase [3.2 +/- 0.2 (+/- SE) pulses/10 h] and increased by the early follicular phase (8.0 +/- 0.8 pulses/10 h) in the control cycles. The increase in LH pulse frequency was not significantly inhibited by administration of P (6.7 +/- 0.7 pulses/10 h; EF + P). However, during both E2 alone and E2 + P, LH pulse frequency remained low (EF + E2, 3.6 +/- 0.8; EF + E2 + P, 2.0 +/- 0.7 pulses/10 h). The mean plasma FSH concentrations paralleled changes in LH pulse frequency, increasing from the luteal to the early follicular phase in the control cycles and during P injections and remaining low during E2 and E2 + P injections. We conclude that continued exposure to P alone does not maintain GnRH pulse frequency at midluteal phase values and that any effect of P requires the presence of E2. As E2 alone maintained lower LH pulse frequency, E2 may act directly to decrease the pulsatile GnRH secretion or it may potentiate the effects of low (less than 3.2 nmol/L) P concentrations.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. R. McCartney, S. K. Blank, and J. C. Marshall
Progesterone acutely increases LH pulse amplitude but does not acutely influence nocturnal LH pulse frequency slowing during the late follicular phase in women
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E900 - E906.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
H.M. Fatemi, E.M. Kolibianakis, M. Camus, H. Tournaye, P. Donoso, E. Papanikolaou, and P. Devroey
Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial
Hum. Reprod., October 1, 2006; 21(10): 2628 - 2632.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
I. E. Messinis
Ovarian feedback, mechanism of action and possible clinical implications
Hum. Reprod. Update, September 1, 2006; 12(5): 557 - 571.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
S.K. Blank, C.R. McCartney, and J.C. Marshall
The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome
Hum. Reprod. Update, July 1, 2006; 12(4): 351 - 361.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K. Dafopoulos, C.G. Kotsovassilis, S. Milingos, A. Kallitsaris, G. Galazios, E. Zintzaras, P. Sotiros, and I.E. Messinis
Changes in pituitary sensitivity to GnRH in estrogen-treated post-menopausal women: evidence that gonadotrophin surge attenuating factor plays a physiological role
Hum. Reprod., September 1, 2004; 19(9): 1985 - 1992.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. D. Sullivan and S. M. Moenter
Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: Implications for a common fertility disorder
PNAS, May 4, 2004; 101(18): 7129 - 7134.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Welt, Y. L. Pagan, P. C. Smith, K. B. Rado, and J. E. Hall
Control of Follicle-Stimulating Hormone by Estradiol and the Inhibins: Critical Role of Estradiol at the Hypothalamus during the Luteal-Follicular Transition
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1766 - 1771.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. R. McCartney, M. B. Gingrich, Y. Hu, W. S. Evans, and J. C. Marshall
Hypothalamic Regulation of Cyclic Ovulation: Evidence That the Increase in Gonadotropin-Releasing Hormone Pulse Frequency during the Follicular Phase Reflects the Gradual Loss of the Restraining Effects of Progesterone
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2194 - 2200.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Gill, J. L. Sharpless, K. Rado, and J. E. Hall
Evidence That GnRH Decreases with Gonadal Steroid Feedback but Increases with Age in Postmenopausal Women
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2290 - 2296.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Gill, H. B. Lavoie, Y. Bo-Abbas, and J. E. Hall
Negative Feedback Effects of Gonadal Steroids Are Preserved with Aging in Postmenopausal Women
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2297 - 2302.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
I. E. Messinis, S. Milingos, E. Alexandris, I. Mademtzis, G. Kollios, and K. Seferiadis
Evidence of differential control of FSH and LH responses to GnRH by ovarian steroids in the luteal phase of the cycle
Hum. Reprod., February 1, 2002; 17(2): 299 - 303.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Tavaniotou, C. Albano, J. Smitz, and P. Devroey
Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix
Hum. Reprod., April 1, 2001; 16(4): 663 - 667.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. A. Eagleson, M. B. Gingrich, C. L. Pastor, T. K. Arora, C. M. Burt, W. S. Evans, and J. C. Marshall
Polycystic Ovarian Syndrome: Evidence that Flutamide Restores Sensitivity of the Gonadotropin-Releasing Hormone Pulse Generator to Inhibition by Estradiol and Progesterone
J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4047 - 4052.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. R. Smith, J.-K. Zubieta, M. G. del Carmen, R. F. Dannals, H. T. Ravert, H. A. Zacur, and J. J. Frost
Brain Opioid Receptor Measurements by Positron Emission Tomography in Normal Cycling Women: Relationship to Luteinizing Hormone Pulsatility and Gonadal Steroid Hormones
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4498 - 4505.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
C. L. Pastor, M. L. Griffin-Korf, J. A. Aloi, W. S. Evans, and J. C. Marshall
Polycystic Ovary Syndrome: Evidence for Reduced Sensitivity of the Gonadotropin-Releasing Hormone Pulse Generator to Inhibition by Estradiol and Progesterone
J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 582 - 590.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Welt, K. A. Martin, A. E. Taylor, G. M. Lambert-Messerlian, W. F. Crowley Jr., J. A. Smith, D. A. Schoenfeld, and J. E. Hall
Frequency Modulation of Follicle-Stimulating Hormone (FSH) during the Luteal-Follicular Transition: Evidence for FSH Control of Inhibin B in Normal Women
J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2645 - 2652.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
N. A. Klein, D. E. Battaglia, D. K. Clifron, W. J. Bremner, and M. R. Soules
The Gonadotropin Secretion Pattern in Normal Women of Advanced Reproductive Age in Relation to the Monotropic FSH Rise
Reproductive Sciences, January 1, 1996; 3(1): 27 - 32.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society